International Journal of Cardiology Journal
Overview
Publication venue for
- The value of frequent objective risk assessments in heart failure management. 379:100-101. 2023
- Optimized dosing of guideline-directed medical therapies is essential in heart failure with reduced ejection fraction. 370:325-326. 2022
- Biomarkers in heart failure: Relevance in the clinical practice. 363:196-201. 2022
- Diversity in modern heart failure trials: Where are we, and where are we going. 348:95-101. 2022
- Use of plasma renin and aldosterone profiles for prognostication in acute heart failure: A step forward but not ready for prime time. 348:111-112. 2022
- 1,25-dihydroxyvitamin D and cardiometabolic risk in healthy sedentary adults: The FIT-AGEING study. 344:192-198. 2021
- Bridging the palliative care chasm in advanced heart failure. 338:147-149. 2021
- FGF23 predicts outcomes in heart failure but questions remain unanswered. 338:145-146. 2021
- Editorial: Premature death from heart failure among Aboriginal peoples in the Hunter New England region of new South Wales. 337:88-89. 2021
- Healthy weight and prevention of weight gain for cardiovascular disease prevention. 335:128-129. 2021
- Acute myocardial infarction in the young - National Trend Analysis with gender-based difference in outcomes. 301:21-28. 2020
- Age is just a number, not a therapeutic obstacle. 296:26-27. 2019
- Response: Arrhythmias 72 hour post strenuous exercise at a time when cardiac troponin was not elevated. 292:138-138. 2019
- The impact of a 21-day ultra-endurance ride on the heart in young, adult and older adult recreational cyclists. 286:137-142. 2019
- Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention. 275:31-35. 2019
- Is there cardiac safety for the elite athletes?. 261:234-235. 2018
- Lipid intervention in diabetes, metabolic syndrome and beyond. 268:200-201. 2018
- Safety and efficacy of vorapaxar in secondary prevention of atherosclerotic disease: A meta-analysis of randomized control trials. 227:617-624. 2017
- Duration of dual antiplatelet therapy after various drug-eluting stent implantation. 215:157-166. 2016
- Effect of cardiac resynchronization therapy on right ventricular function. 209:34-36. 2016
- Characteristics, quality of care, and in-hospital outcomes of Asian-American heart failure patients: Findings from the American Heart Association Get With The Guidelines-Heart Failure Program. 189:141-147. 2015
- Risk of major bleeding in different indications for new oral anticoagulants: Insights from a meta-analysis of approved dosages from 50 randomized trials. 179:279-287. 2015
- Association between obesity and severity of coronary artery disease at the time of acute myocardial infarction: Another piece of the puzzle in the "obesity paradox". 176:247-249. 2014
- Meta-analysis of coronary computed tomography angiography versus standard of care strategy for the evaluation of low risk chest pain: Are randomized controlled trials and cohort studies showing the same evidence?. 177:238-245. 2014
- Association between obesity and infarct size: Insight into the obesity paradox. 167:604-606. 2013
Identity
International Standard Serial Number (ISSN)
- 0167-5273